Bromide

Bromide

SCHEMBL4380648

B.Br

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL1376657 1.00
Bromide SCHEMBL12468528 1.00
Bromide SCHEMBL195870 1.00
Bromide SCHEMBL11661793 1.00
Bromide SCHEMBL3454710 1.00
Bromide SCHEMBL195871 1.00
Bromide SCHEMBL11261847 0.82
Bromide SCHEMBL9705557 0.82
Bromide SCHEMBL28016847 0.82
Bromide SCHEMBL2326489 0.82

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118026887-A Organic ligand for preparing catalyst of high isotactic poly-1-butene, preparation method and application thereof 中国科学院青岛生物能源与过程研究所 2024-05-14 CN claimed
US-11941485-B2 Method of making a quantum device COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2024-03-26 US claimed
EP-4006997-B1 METHOD FOR MANUFACTURING A QUANTUM DEVICE COMMISSARIAT ENERGIE ATOMIQUE (FR) 2023-10-25 EP claimed
US-11404645-B2 Direct singlet capture organic molecules with short emission decay time and application thereof in optoelectronic devices SICHUAN KNOWLEDGE EXPRESS INSTITUTE FOR INNOVATIVE TECHNOLOGIES CO., LTD (CN) 2022-08-02 US claimed
US-20220172093-A1 METHOD OF MAKING A QUANTUM DEVICE COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (FR) 2022-06-02 US claimed
EP-4006997-A2 METHOD FOR MANUFACTURING A QUANTUM DEVICE Commissariat à l'Energie Atomique et aux Energies Alternatives (FR) 2022-06-01 EP claimed
US-12458922-B2 Electroactive species and method for electrochemical gas separation VERDOX, INC. (US) 2025-11-04 US disclosed
US-20250312733-A1 METHOD FOR ELECTROCHEMICAL GAS SEPARATION VERDOX INC (US) 2025-10-09 US disclosed
US-12364949-B2 Method for electrochemical gas separation VERDOX, INC. (US) 2025-07-22 US disclosed
WO-2024186616-A1 REACTIVE SECONDARY BORANES AND METHODS FOR SYNTHESIS THEREOF BAYLOR UNIVERSITY (US) 2024-09-12 WO disclosed
US-20240300982-A1 REACTIVE SECONDARY BORANES AND METHODS FOR SYNTHESIS THEREOF BAYLOR UNIVERSITY (US) 2024-09-12 US disclosed
US-20240173668-A1 METHOD FOR ELECTROCHEMICAL GAS SEPARATION VERDOX, INC 2024-05-30 US disclosed
CN-118026887-A Organic ligand for preparing catalyst of high isotactic poly-1-butene, preparation method and application thereof 中国科学院青岛生物能源与过程研究所 2024-05-14 CN disclosed
EP-1467998-B1 TETRACYCLIC HETEROCOMPOUNDS AS ESTROGEN RECEPTOR MODULATORS ORTHO MCNEIL PHARM INC (US) 2006-03-29 EP disclosed
EP-1569939-A1 NOVEL HETEROATOM CONTAINING TETRACYCLIC DERIVATIVES AS SELECTIVE ESTROGEN RECEPTOR MODULATORS Ortho-Mcneil Pharmaceutical, Inc. (US) 2005-09-07 EP disclosed
US-20040259915-A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators KANOJIA RAMESH M (US) 2004-12-23 US disclosed
EP-1467998-A1 TETRACYCLIC HETEROCOMPOUNDS AS ESTROGEN RECEPTOR MODULATORS Ortho-Mcneil Pharmaceutical, Inc. (US) 2004-10-20 EP disclosed
WO-2004050660-A1 NOVEL HETEROATOM CONTAINING TETRACYCLIC DERIVATIVES AS SELECTIVE ESTROGEN RECEPTOR MODULATORS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2004-06-17 WO disclosed
US-20030216463-A1 Novel heteroatom containing tetracyclic derivatives as selective estrogen receptor modulators ORTHO-MCNEIL PHARMACEUTICAL, INC. 2003-11-20 US disclosed
WO-2003053977-A1 TETRACYCLIC HETEROCOMPOUNDS AS ESTROGEN RECEPTOR MODULATORS ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2003-07-03 WO disclosed